Skip to main content

Journey Medical Corp

DERM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001867066

No open-market purchases or sales by Journey Medical Corp insiders were filed in the last 90 days; 71 institutions reported holding it in 13F filings for Q2 2026, worth $75.2M in total; no superinvestor holds it.

Q2 2024 vs. Q1 2024

How the institutions holding Journey Medical Corp changed between Q1 2024 and Q2 2024.

All holders in Q2 2024All holders in Q1 2024

13F holders of DERM: Q1 2024 compared with Q2 2024
MeasureQ1 2024Q2 2024Change
Holders3335+2
Shares1.82M2.36M+543.6K (+29.9%)
Value$6.68M$13.3M+$6.63M (+99.3%)

New holders (13)

Institutions that held Journey Medical Corp at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to DERM in Q2 2024
InstitutionSharesValue% of portfolio
Cambridge Investment Research Advisors, Inc.294,950$1.66M0.01%
PVG Asset Management Corp158,540$894.2K3.54%
Rosalind Advisors, Inc.114,132$643.7K0.51%
Geneos Wealth Management Inc.63,280$356.9K0.02%
Integrated Wealth Concepts LLC61,350$346.0K0.00%
Atria Investments LLC55,337$312.1K0.00%
Gladstone Institutional Advisory LLC33,481$188.8K0.01%
Cetera Investment Advisers18,613$105.0K0.00%
TMD Wealth Management, LLC11,605$65.5K0.01%
Virtu Financial LLC10,542$59.0K0.00%
Transcendent Capital Group LLC500$2.82K0.00%
Advisor Group Holdings, Inc.400$2.26K0.00%
Federation des caisses Desjardins du Quebec300$1.69K0.00%

Sold out (11)

Institutions that held Journey Medical Corp at the end of Q1 2024 and filed for Q2 2024 without it.

Institutions that sold out of DERM in Q2 2024
InstitutionShares, Q1 2024Value, Q1 2024
XTX Topco Ltd36,548$134.5K
Millennium Management LLC36,117$132.9K
Heron Bay Capital Management33,669$123.9K
Goldman Sachs Group Inc19,965$73.5K
Prelude Capital Management, LLC15,060$55.4K
Nwam LLC11,820$40.7K
IFP Advisors, Inc3,403$12.5K
GWM Advisors LLC2,124$7.82K
Morgan Stanley550$2.02K
Wells Fargo & Company61$224
Lazard Asset Management LLC251$0